Drug product
Amlodipine and Valsartan Tablets USP 5 mg/160 mg, 30-count bottles, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc., Dayton, NJ 08810. NDC 65862-737-30
D-0361-2019
Product summary
- Event
- Event 81887
- Status
- Ongoing
- Classification
- Class II
- Quantity
- 18,408 bottles
- Official record key
drug-enforcement:D-0361-2019
Official wording
Reason: CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.
Code information: Lot # VESA17013-A, exp. 10/2019 Lot # VESA17014-A, exp. 10/2019 Lot # VESA18001-A, exp. 12/2019 Lot # VESA18002-A, exp. 12/2019
Distribution pattern: Product was distributed to 25 distributors and Retail Chains who may have further distributed the product throughout the United States.
Derived failure modes
-
Foreign material or chemical contamination
impurity, N-nitrosodimethylamine (NDEA
-
Manufacturing or process control
CGMP Deviations